Phenobarbital-induced expression of cytochrome P450 genes

被引:27
作者
Czekaj, P [1 ]
机构
[1] Med Univ Silesia, Dept Histol & Embryol 2, PL-40752 Katowice, Poland
关键词
cytochrome p450; phenobarbital; phenobarbital-responsive enhancer unit; orphan receptors; CAR; PXR; CYP2B; CYP3A; CYP2H1;
D O I
10.18388/abp.2000_3962
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In contrast to the well-known Ah receptor-mediated regulation of the CYP1A1 gene by polycyclic aromatic hydrocarbons, the molecular mechanism by which phenobarbital (PB) and PB-like inducers affect transcription of CYP genes remains unknown; no receptor for these chemicals has been found to date. However, in the last 5 years PB-responsive sequences have been identified in the 5' flanking regions of several P450 genes. The phenobarbital-responsive enhancer unit (PBRU) of CYP2B gene family members contain two potential nuclear receptor binding sites (NR1 and NR2) that flank a nuclear factor 1 (NF-1) binding motif. The nuclear factors that regulate PBRU activity have not yet been characterized. It seems that PB may activate multiple nuclear orphan receptors to induce various CYP genes. CYP2B and CYP3A genes appear to be targets for the orphan receptors CAR and PXR, respectively. It is also possible that the pleiotropic effects of PB can, in part, be explained by the ability of the CAR-RXR heterodimer to bind to a variety of nuclear receptor binding motifs. The induction of cytochromes P450 may result in interactions between xenobiotics and in the interference of xenobiotic metabolism and endogenous signalling pathways.
引用
收藏
页码:1093 / 1105
页数:13
相关论文
共 57 条
[1]   A mechanistic approach to antiepileptic drug interactions [J].
Anderson, GD .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) :554-563
[2]   FREE-RADICALS IN TOXICOLOGY [J].
AUST, SD ;
CHIGNELL, CF ;
BRAY, TM ;
KALYANARAMAN, B ;
MASON, RP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 120 (02) :168-178
[3]   A NEW ORPHAN MEMBER OF THE NUCLEAR HORMONE-RECEPTOR SUPERFAMILY THAT INTERACTS WITH A SUBSET OF RETINOIC ACID RESPONSE ELEMENTS [J].
BAES, M ;
GULICK, T ;
CHOI, HS ;
MARTINOLI, MG ;
SIMHA, D ;
MOORE, DD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1544-1552
[4]   EXPRESSION OF PULMONARY CYTOCHROME P4501A1 AND CARCINOGEN DNA ADDUCT FORMATION IN HIGH-RISK SUBJECTS FOR TOBACCO-RELATED LUNG-CANCER [J].
BARTSCH, H ;
CASTEGNARO, M ;
ROJAS, M ;
CAMUS, AM ;
ALEXANDROV, K ;
LANG, M .
TOXICOLOGY LETTERS, 1992, 64-5 :477-483
[5]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[6]   Polymorphisms in xenobiotic conjugation and disease predisposition [J].
Brockmöller, J ;
Cascorbi, I ;
Kerb, R ;
Sachse, C ;
Roots, I .
TOXICOLOGY LETTERS, 1998, 103 :173-183
[7]  
Chang TKH, 1997, CANCER RES, V57, P1946
[8]  
Chen JY, 1997, DRUG METAB DISPOS, V25, P1165
[9]   Inhibiting effect of ethinylestradiol/levonorgestrel combination on microsomal enzymatic activities in rat liver and kidney [J].
Czekaj, P ;
Nowaczyk-Dura, G .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (03) :243-248
[10]  
CZEKAJ P, 2000, ACTA POL TOXICOL, V1, P17